Search
Rosuvastatin
go.drugbank.com/drugs/DB01098ApprovedInvestigational[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD … of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]'s effects on
Products: ROSUSTAR ® 40 MG TABLETA CON PELÍCULA/ TABLETA RECUBIERTA.Dofetilide
go.drugbank.com/drugs/DB00204ApprovedInvestigationalDofetilide is a class III antiarrhythmic agent that is approved by the Food and Drug Administration (FDA) for the maintenance of sinus rhythm in individuals prone to the formation of atrial fibrillation and flutter, and for the chemical ...
Neutrophil elastase
go.drugbank.com/bio_entities/BE0000394TargetEnzymeHumansSerine protease that modifies the functions of natural killer cells, monocytes and granulocytes (PubMed:15140022). Shows microbicidal activity in neutrophils by mediating cleavage and degradation of bacterial proteins (PubMed:10947984, P...
Synonyms: Bone marrow serine proteaseBemcentinib
go.drugbank.com/drugs/DB12411InvestigationalBemcentinib has been investigated for the treatment of Non-Small Cell Lung Cancer.
KDT-3594
go.drugbank.com/drugs/DB17085InvestigationalKDT-3594 is a non-ergot dopamine receptor agonist developed by Kissei Pharmaceutical.
Agrostis stolonifera pollen
go.drugbank.com/drugs/DB10962ApprovedAgrostis stolonifera pollen is the pollen of the Agrostis stolonifera plant. Agrostis stolonifera pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractLolium perenne subsp. multiflorum pollen
go.drugbank.com/drugs/DB10964ApprovedLolium perenne subsp. multiflorum pollen is the pollen of the Lolium perenne subsp. multiflorum plant. Lolium perenne subsp. multiflorum pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractNaveglitazar
go.drugbank.com/drugs/DB12662InvestigationalNaveglitazar has been used in trials studying the treatment of Diabetes Mellitus, Non-Insulin-Dependent.
Tucatinib
go.drugbank.com/drugs/DB11652ApprovedInvestigationalIt was developed by Seattle Genetics and approved by the FDA on April 17, 2020.